Global Markets Direct’s, ‘Malignant Mesothelioma – Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action , route of administration and molecule type, along with latest updates, and featured news and press releases.
